What early PK/TK mistakes should you watch out for during drug development? This week, Sheridan Jaeger provides insight on what to watch for early on in your program including study design, dosing and sampling strategy, and timing. Have a question you want Alturas PK team to address? Let us know: https://lnkd.in/gttuktYk
Alturas Analytics, Inc.
Biotechnology
Moscow, Idaho 1,413 followers
"Your Partner in Success"
About us
At Alturas Analytics, we deliver results on time with the highest level of integrity. Our business is built on developing long term collaborations with our clients by providing advanced MS/MS solutions through a focused emphasis on teamwork, communication and exceptional science. Alturas has a proven record with complex analysis supporting drug candidates for the pharmaceutical and biotechnology industries, from discovery through phase IV clinical trials. The company operates in a GLP environment using validated operational processes in strict adherence to internal SOPs and applicable global regulations. Bioanalytical services routinely performed include the following: • GC-MS/MS and LC-MS/MS bioanalysis – allows for the broadest range of chemical properties across a wide mass range • GLP and non-GLP bioanalysis of large and small molecules in any matrix • Quantitative Antibody Drug Conjugates (ADC) analysis • Biomarker quantitation • Protein binding estimations • Dried Blood (DBS) and Matrix Spot (DMS) analysis (limited sample volume ex. pediatrics, CSF, tears) Ensuring that a project is completed on time to a company's specifications demands clear lines of communication before, during, and after a study's completion. Clients have direct access to a team of professionals who understand the critical nature of the business. An Alturas Study Director is assigned to each client based on their working knowledge with compounds of similar chemical properties. Comments & Feedback: "Thanks. We owe a lot to Alturas for the great nonclinical and clinical bioanalytical support for the program. Happy 2013!" January 2013: Comment from a Sponsor after receiving FDA Approval. “You solved all of our bioanalytical problems.” Comment from a Sponsor after the Alturas Team was able to address technical difficulties. "Five Stars. Would definitely use Alturas again for upcoming projects." Comment from a Sponsor in 2016.
- Website
-
http://www.alturasanalytics.com
External link for Alturas Analytics, Inc.
- Industry
- Biotechnology
- Company size
- 51-200 employees
- Headquarters
- Moscow, Idaho
- Type
- Privately Held
- Founded
- 2000
- Specialties
- Regulated Bioanalysis, Small and Large Molecule Bioanalysis, Biomarker Analysis, Method Development & Validation, Protein Binding, Antibody Drug Conjugate (ADC) Analysis, Discovery bioanalysis, and Pharmacokinetic/Toxicokinetic Analysis
Locations
-
Primary
Get directions
1324 Alturas Drive
Moscow, Idaho 83843, US
Employees at Alturas Analytics, Inc.
Updates
-
When the Numbers Don’t Add Up: Resolving Sample Metadata Issues in a Bioanalytical CRO 🗓 September 17, 2025 | ⏰ 10 AM PT Presented by Elizabeth Walker Moderated by Julian Cossel A small metadata error nearly caused a big problem. Sound familiar? In our upcoming webinar, Elizabeth Walker shares the story of how a routine check uncovered a sample data issue that could’ve seriously impacted a study—and what it took to fix it. We’ll talk through what went wrong, how the team resolved it, and what we learned that can help others avoid the same pitfall. You'll also get practical tips on how to: ✔️ Spot issues before they become real problems ✔️ Build a sample management team that actually works ✔️ Keep communication flowing across labs, CROs, and sponsors If you’ve ever had to clean up a data mess—or want to avoid one—this one’s for you. 🔗 Register Here: https://buff.ly/JfP7fvp
-
-
Excited to share pharmakokinetic and toxicokinetic expertise from Alturas’ Ryan Schmich.
What is PK/TK and why does it matter in drug development? Alturas Associate Pharmacokineticist Ryan Schmich gives insight on the importance of pharmacokinetic and toxicokinetic studies during drug development. Have something you’ve always wanted explained more clearly? Curious how these concepts apply to your specific challenge? Ask Our Experts — submit your PK/TK questions and we may feature them in our weekly video updates: https://lnkd.in/gAqfTwAn Download the PK/TK 101 Cheat Sheet — your quick reference to the basics: https://lnkd.in/gvpcWyGZ
-
What is PK/TK and why does it matter in drug development? Alturas Associate Pharmacokineticist Ryan Schmich gives insight on the importance of pharmacokinetic and toxicokinetic studies during drug development. Have something you’ve always wanted explained more clearly? Curious how these concepts apply to your specific challenge? Ask Our Experts — submit your PK/TK questions and we may feature them in our weekly video updates: https://lnkd.in/gAqfTwAn Download the PK/TK 101 Cheat Sheet — your quick reference to the basics: https://lnkd.in/gvpcWyGZ
-
Data quality isn’t optional in clinical research—it’s foundational. Even small errors in sample collection metadata can lead to significant delays, regulatory concerns, and questionable study outcomes. Join Elizabeth Walker and Julian Cossel on September 17, 2025, for a webinar exploring a real-world case where a routine review uncovered a metadata issue—and how it was resolved. We’ll also share best practices for ensuring accurate sample metadata and discuss what effective sample management looks like across labs, CROs, and sponsors. 📅 September 17, 2025 | 10 AM PT 🔗 Register here: https://buff.ly/DlC0nLL Precision in the small things ensures confidence in the big ones. #ClinicalResearch #DataIntegrity #SampleManagement #Webinar #RegulatoryCompliance #GxP
-
-
Alturas Analytics, Inc. reposted this
📣 Webinar Alert! 📣 Join Chad Christianson for this upcoming American Association of Pharmaceutical Scientists (AAPS) | @aapscomms eChalk Talk, "Free vs. Bound: What Regulators Expect (and Why It Matters) in ADC Payload Analysis." We look forward to seeing you September 10 at 1:15 PM ET. Register here >>> https://buff.ly/TWX8SAt #ADCs #bioanalysis #bioanalytical #LCMS #theAlturasWay
-
-
📣 Webinar Alert! 📣 Join Chad Christianson for this upcoming American Association of Pharmaceutical Scientists (AAPS) | @aapscomms eChalk Talk, "Free vs. Bound: What Regulators Expect (and Why It Matters) in ADC Payload Analysis." We look forward to seeing you September 10 at 1:15 PM ET. Register here >>> https://buff.ly/TWX8SAt #ADCs #bioanalysis #bioanalytical #LCMS #theAlturasWay
-